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The transfer of Bromsulphthalein  (BSP)  (Hynson, Westcott, and Dunning,  Inc., 
Baltimore, Md.) from plasma to hepatocyte may be mediated in part by a protein that 
can be isolated from the cell supernatant fraction of a liver homogenate. By virtue of 
its binding capacity/or a variety of organic anions, including BSP, this protein, desig- 
nated "Y" protein (1)  or ligandin (2), is believed to be a  determinant of the hepatic 
uptake process. This view is supported by the association of "physiological" jaundice 
with a  low concentration of Y  protein in fetal and neonatal liver (3,  4), as well as 
phylogenetic evidence demonstrating a  correlation between the rate of clearance of 
BSP from plasma and the presence of Y protein in liver (5). 
BSP is excreted in bile mainly as the glutathione conjugate that is synthesized in 
the liver (6).  The conjugation step is considered to be rate-limiting in  the  overall 
hepatic transport of BSP from plasma to bile (7,  8). Liver cytosol has been shown to 
contain a soluble enzyme that catalyses the conjugation of BSP with glutathione--the 
glutathione S-aryltransferase enzyme (9,  10). 
During studies of the binding of BSP and other anions to Y  protein, dupli- 
cating precisely the conditions described in detail by Levi et al.  (1), BSP con- 
jugation with glutathione was found  to occur. Further evaluation of this phe- 
nomenon,  which  forms  the  basis of  this  report,  has  led  us  to  the  conclusion 
that ¥  protein may act by both binding and conjugating BSP. 
Materials and Methods 
The liver donors were albino Wistar strain rats weighing approximately 250 g. The livers 
were perfused  in situ with 0.01 M phosphate buffer, pH 7.4, 0.25 M sucrose. 25% liver ho- 
mogenates were prepared in the same buffer and the supernatant fraction was harvested after 
centrifuging  at 100,000 g for 60 rain. 
Gel filtration was performed  on  Sephadex  G-75 (Pharmacia,  Uppsala,  Sweden)  columns 
30 X 2.9 cm using 0.01 NI phosphate buffer, pH 7.4, containing 0.I M NaC1 as mobile phase. 
Flow rate was 28 ml/h, 10 fractions/h. 
BSP was obtained from Vitarine Co., Inc., New York, and [2-3H]glycine glutathione was 
obtained from New England Nuclear,  Boston,  Mass. (specific radioactivity, 285 mCi/#mol). 
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Glutathione S-aryltransferase  activity was measured using either [aSS]BSP  and glutathione 
as eosubstrates (9) or 3,4-dichloronitrobenzene  and glutathione as cosubstrates (10). 
:  :  -  RESULTS 
Using  BSP  binding  as  a  protein  marker,  three  protein  fractions  may  be 
identified  with  elution  vol  of  75,  95,  and  135  ml,  respectively (Fig. 1). The 
second protein corresponds to Y  protein.  [aH]Glycine glutathione  was  eluted 
as two peaks: a minor peak  (elutio  n vol 75 ml)  and a large symmetrical peak 
(elution vol 95  ml).  The latter peak is shown  to correspond closely with the 
presence of BSP bound,to ¥  protein (Fig.  i). Since a similar pattern of gluta- 
thione binding was  also found in the absence of BSP, the glutathione binding 
does not represent bound BSP-glutathione conjugate. 
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FIG. 1.  Elution pattern from Sephadex G-75 column  of liver cell supernatant (4.0 ml) with 
added BSP (4.0 rag) and [aH]glycine  glutathione (2.5 #Ci). 
Fractions corresponding to elution vol 65-80, 81-105, 106-125, and 125-150 
ml  were  combined  and  glutathione  S-aryltransferase  activity  was  assayed 
using BSP  as substrate  (Table I). Activib" greater than control was present 
only in the combined fractions corresponding to Y protein. 
When glutathione S-aryltransferase activity was assayed with 3,4-dichloroni- 
trobenzene  in  each  individual  fraction  from  the  Sephadex  column,  a  close 
correspondence with the elution pattern of [aH]glycine glutathione was found 
(Fig. 2). Enzvme activity was found only in the fractions corresponding to Y 
protein. 
DISCUSSION 
Sephadex  gel  filtration  permits  separation  of  proteins  according  to  their 
molecular weights (11). The addition of the organic anion, BSP, to the hepatic 
supernatant fraction undergoing molecular sieving has led to the identification KAPLOWITZ ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE I 
Conjugation  of BSP  and  Glutathione  by  Liver  Supernatant  Protein  Fractions 
485 
Radioactivity  psS] 
Elution vol  Percentage conjugation 
BSP  BSP conjugate 
ml  cpm  % 
65-80  1,205  64  5.0 
81-105  738  743  50.2 
106-125  1,697  103  5.7 
125-150  1,361  80  5.5 
psS]BSP (1 raM) and reduced glutathione (8 raM) were incubated in 0.01 M  phosphate 
buffer, pH 7.4, at 37°C for 60 rain together with an aliquot of the protein-containing  fractions. 
Conjugated and unconjugated BSP were separated by thin-layer chromatography and radio- 
activity was estimated by liquid scintillation counting.  Nonenzymic conjugation of BSP and 
glutathione produces approximately 5% conjugation under these conditions. 
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FIG. 2.  Elution pattern of liver cell supernatant (2.0 ml) with added [3H]glycine glutathione 
(2.5/zCi). The maximum enzyme activity has been arbitrarily  given a value of 1.0 and activity 
present in each fraction is plotted as a proportion of this maximum. 
of a  series of anion-binding proteins,  one of which  has been  called Y  protein 
(1)  or  ligandin  (2).  We  have  demonstrated  that  the  elution  volume  of  the 
BSP  marking Y  protein and  the elution volume of glutathione are the same. 
This  suggests  that  glutathione  binds  to  the  same  protein  as  BSP  and  that 
glutathione  may  therefore  be  used  as  an  alternative  marker  for  Y  protein 
during  gel  filtration. 
Since BSP and glutathione are cosubstrates for the hepatic supernatant en- 
zyme,  glutathione  S-aryltransferase,  the  finding  of  nearly  superimposable 
peaks  for  these  two  substances  corresponding to  hepatic  supernatant  Y  pro- 
tein suggested the possibility that enzymic activity might reside in these frac- 
tions. Using two different assay systems, this enzyme activity was  found to be 486  KAPLOWITZ  ET  AL.  BRIEF  DEFINITIVE  REPORT 
present  in  those  fractions  containing  Y  protein,  and  the  pattern  of activity 
corresponded with the pattern of glutathione; no activity was detected  in any 
other fractions (Fig. 2).  We are thus led to conclude that a close relationship, 
if not  identity,  exists  between  Y  protein  and  glutathione  S-aryltransferase. 
Further purification of the enzyme will permit us to make an exact comparison 
of its physical and chemical properties with those published  for Y protein  (2). 
This  newly  proposed  function  for  Y  protein  as  a  glutathione-conjugating 
enzyme should lead to a reappraisal of its role in the hepatocellular uptake of 
organic  anions from plasma. The significance of binding of anions other than 
BSP  must be assessed  with  particular  reference  to possible inhibition  of en- 
zymic activity as well as to other anions acting as substrates for the enzymes. 
For example,  bilirubin  and  cholecystographic  agents  have been shown  to be 
bound by Y  protein and thus might inhibit the rate-limiting glutathione con- 
jugation step in BSP transport. This would provide an explanation for the clin- 
ical impairment of plasma BSP clearance seen in liver disease or during biliary 
tract  radiography.  Thus,  ligandin  may participate  in  the  hepatic  transport 
process in two ways: as an intracellular binding protein in the hepatic uptake 
of organic anions and  as an enzyme that further metabolizes certain of these 
compounds. 
SUMMARY 
Using gel filtration,  the binding of both glutathione  and  Bromsulphthalein 
(BSP)  to  a  liver-soluble protein  was found  to  be identical.  BSP-conjugating 
activity  (glutathione  S-aryltransferase)  was  present  only  in  the  fractions 
corresponding  to  the  two  protein-bound  markers.  Using  a  highly  sensitive 
assay,  with  3,4-dichloronitrobenzene,  the pattern  of glutathione S-aryltrans- 
ferase activity was found  to coincide with Y  protein.  This evidence suggests 
that Y protein, or ligandin, has a dual role in hepatic transport:  a specific en- 
zymic function in the conjugation of certain anions with glutathione in addition 
to a transport function in the intracellular binding of organic anions. 
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